chrisvoncsefalvay/vaers-outcomes huggingface dataset:
todos los mismos síntomas que cuando tuvo covid-19; sentía mucho frío; dolor de huesos; se le quitó el hambre; escalofríos; dolor de cabeza; tenía que ir al baño a cada rato; no pudo comer porque cualquier cosa la vomitaba; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (todos los mismos síntomas que cuando tuvo covid-19), FEELING COLD (sentía mucho frío), BONE PAIN (dolor de huesos), DECREASED APPETITE (se le quitó el hambre) and CHILLS (escalofríos) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 07C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced VACCINATION COMPLICATION (todos los mismos síntomas que cuando tuvo covid-19), FEELING COLD (sentía mucho frío), BONE PAIN (dolor de huesos), DECREASED APPETITE (se le quitó el hambre), CHILLS (escalofríos), HEADACHE (dolor de cabeza), NAUSEA (tenía que ir al baño a cada rato) and VOMITING (no pudo comer porque cualquier cosa la vomitaba). On 02-May-2021, VACCINATION COMPLICATION (todos los mismos síntomas que cuando tuvo covid-19), DECREASED APPETITE (se le quitó el hambre), NAUSEA (tenía que ir al baño a cada rato) and VOMITING (no pudo comer porque cualquier cosa la vomitaba) had resolved. At the time of the report, FEELING COLD (sentía mucho frío), BONE PAIN (dolor de huesos), CHILLS (escalofríos) and HEADACHE (dolor de cabeza) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were  not provided. No Treatment details were provided.   This case was linked to MOD21-087003, MOD21-087004, MOD21-087005, MOD21-087006, US-MODERNATX, INC.-MOD-2021-107093 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Non significant follow up received and contains no new information; Sender's Comments:  MOD21-087003:cross linked id MOD21-087004:cross linked id MOD21-087005:cross linked id MOD21-087006:cross linked id US-MODERNATX, INC.-MOD-2021-107093:
The injection site is itchy.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (The injection site is itchy.) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M209) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (The injection site is itchy.). At the time of the report, VACCINATION SITE PRURITUS (The injection site is itchy.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications include Diabetes medications  Patient used alcohol as treatment to get some relief.
Starting that evening of the vaccine,  I had a mild fever. Then, I developed a headache, severe joint pain and muscle pain that night. I waited 2 weeks to see if it would go away on its own. It did not, so I called the doctor and they did blood work. It showed elevated sed rate/inflammatory markers and was put on steroids off and on for at least 3 months. I ended up seeing a vascular surgeon to check on my leg to make sure the pain was not coming from poor circulation. Told to wear compression socks. I was sent to see a urologist due to decreased kidney function. Increasing fluids helped my kidney function to come back normal. Also, I developed blurry vision and swelling around the eyes, so I saw an ophthalmologist to rule out any issues. I was given steroid eye drops and I used them for a bit of time off and on as well. Also, I felt weak/tired during this event. I was sent to see a neurologist and get an MRI of the head to ensure I did not have a blood clot for the severe headaches. My hair started falling out around the same time, and was seen by a dermatologist who said it was likely due to severe medical stress. I had to use rogaine to help the hair grow back. My SED rate has not gone back to normal, hence why I was told to get a different booster shot.
Information has been received from a registered nurse concerning an 18 year old female patient who was vaccinated with the first dose of GARDASIL (lot number not reported) on 22-AUG-2007, the second dose (lot number not reported) on 29-NOV-2010, and the third dose (lot number 666987/1016Z, expiry on 22-NOV-2012) on 12-APR-2011. On an unspecified date, after getting her third GARDASIL dose, the patient developed "lymphadenitis and was vomiting every day". She was admitted to hospital for 10 days. Tests for aluminum were performed, no results provided. "There was some kind of intervention done, but I'm not sure what". At the time of this report, the patient's outcome was unknown. Lymphadenitis and vomiting every day were considered to be other important medical events by the registered nurse. Additional information has been requested.
10 minutes after the patient recieved the vaccine, he felt dizzy, noxious, and sweatting for about 30 min
Patient is complaining of nerve pain and says she can barely move her arm. Also is concerned about a scratch on her skin.
Information has been received from a Registered Nurse referring to a 9 week old patient of unknown gender. Information about patient's concurrent conditions and medical history was not reported. On 22-JUN-2015 the patient was vaccinated with a dose of improperly stored PEDVAXHIB (route not reported, lot # reported as K025004, dose 0.5 (unit not provided)). Concomitant medications were not provided. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. On unknown dates these patients were vaccinated with VARIVAX (Merck) (dose, route and lot# were not reported). On unknown dates these patients experienced injection site pain after receiving VARIVAX (Merck). The reporter stated that injection site pain in the other unspecified patients experienced with M-M-R II was more painful compared to the injection site pain the unspecified patients experienced with VARIVAX (Merck). The reporter also reported that all of these unspecified patients cried after receiving VARIVAX (Merck) because the injections were so "uncomfortable." No treatment was given for these adverse events. No lab diagnostics studies were performed. The outcome of these events was reported as recovered/resolved. The relationship between discomfort and VARIVAX (Merck) was related, the relationship between other events and VARIVAX (Merck) was not reported. This one of several cases reported by the same reporter. Additional information has been requested.
Pt recv vax on 10/27/98; on 11/16/98 pt exp crying uncontrollable, irritable, knot in Rt arm w/ tenderness, pt did not move leg 4 -5 day
shooting pain down both arms; shooting pain down both arms; This is a spontaneous report from a contactable consumer (patient). A 63-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in Arm Right on 25May2021 (Batch/Lot Number: EW0185) as single dose for COVID-19 immunisation. Medical history included 8 years ago he threw his back out at work and his left leg died almost overnight, lost all the muscle, it was just bone, caller was tearful, 4 years ago he had a viral infection and abscess on L4, L5, vertebrae. There were no concomitant medications. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (Batch/lot number: EW0171), administered in right arm on an unspecified date for COVID-19 immunisation. It was reported that the patient got second shot on 25May2021 and his arms were killing him. Got shot in right arm and it was his left arm that was having a constant shooting pain that goes all the way down his arm. The patient stated that he will just be relaxing and then all of a sudden the arm would feel like he was having a shot in his arm, he could feel the veins popping out of his wrist, and felt like they were stretching. Patient called his doctor but they will not call him back. The patient was encouraged to reach out to a HCP or urgent care for any medical advice. There was no investigation assessment. Outcome of the events was not recovered.
Patient was in hospital and received plasma December 10th 2020. While in rehab facility in January 2021, patient received first dose of Covid vaccine even though it hadn?t been 90 days since receiving plasma.  No adverse effects reported.
hives: sensation of blood in upper extremities being warm. Sensitivity to all fabric anything touching skin. Took Zyrtec for 2 months.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old male patient received BNT162b2 (BNT162B2), on 20Mar2021 as dose 1, single (Lot number: ER2613), in left arm, on 14Apr2021 at 10:00 as dose 2, single (Lot number: EW0169), in left arm, on 01Oct2021 at 13:00 as dose 3 (booster), single (Lot number: FC3184), in left arm and on 11Apr2022 at 13:00 as dose 4 (booster), single (Lot number: FM0698) at the age of 61 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Central Sensitization" (unspecified if ongoing); "Known allergies: Yes" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (29Aug2022) Negative, notes: Roche home antigen test resulted negative 29Aug2022; (31Aug2022) Positive, notes: Roche home antigen test resulted positive on 31Aug2022. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Additional information: The patient was treated with PAXLOVID for COVID 19 Treatment from 23Aug2022 to 27Aug2022 (lot number: GA6765). Rebound symptoms on 30Aug2022 16:00 also reported as [day 2 (31Aug2022)] after stopping Paxlovid. Roche home antigen test resulted negative 29Aug2022. Roche home antigen test resulted positive on 31Aug2022.
VERY sore & swollen red and itchy eyes-all of a sudden, hoarseness, cough, sore throat. All had fever and body aches. All lasted just over 12 hours. It was very miserable.
Heaviness feeling in injection site arm; shivering / chills; night sweats; tenderness at injection site; This case was reported by a consumer via call center representative and described the occurrence of heaviness in arm in a 85-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included cataract (right eye surgery on 23rd January 2020) and glaucoma. Concomitant products included thyroxine sodium (Levothyroxine), brimonidine tartrate (Alphagan) and latanoprost (Xalatan).   On 17th January 2020, the patient received the 1st dose of Shingrix (intramuscular). On 17th January 2020, less than a day after receiving Shingrix, the patient experienced injection site tenderness. On 27th January 2020, the patient experienced shivering and night sweat. On 19th March 2020, the patient experienced heaviness in arm. On an unknown date, the outcome of the heaviness in arm, injection site tenderness and night sweat were recovering/resolving and the outcome of the shivering was recovered/resolved.   It was unknown if the reporter considered the heaviness in arm, injection site tenderness, shivering and night sweat to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in right arm. The patient planned to continue follow-up with her physician on an unknown date. Consented to follow up.
Patient was given booster of Moderna right dose but he would be 18 in two months. Call to patient, No adverse reaction & he states he asked for Moderna not for Pfizer. No adverse effect.
Experiencing like stuffy nose with her sinuses; Developed form of hive on her nose and her sinuses; feel like stuffy head; This is a spontaneous report from a contactable consumer (patient). An 82-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL3248), via an unspecified route of administration on 18Jan2021 at single dose for covid-19 immunization. The patient medical history was not reported. Concomitant drugs includes levothyroxine sodium which reported as generic for Synthroid. The patient experienced like stuffy nose with her sinuses, developed form of hive on her nose and her sinuses; seems like her sinuses; she felt like stuffy head. The patient wanted to know is that a side effects or a normal reaction. Therapeutic measures were taken as a result of experiencing like stuffy nose with her sinuses includes like Tylenol. The outcome of the events was unknown.
This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007320A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 04-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnant). On 04-Feb-2021, EXPOSURE DURING PREGNANCY (pregnant) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Injection site reaction Narrative: Pt received 1st dose of Moderna vaccine on 09/01/21 and reports injection site reaction on 09/12/21, specifically injection site pain/discomfort, redness, and itching, No other side effects reported at that time. No other information provided either.
SOB x 1 day, nausea x 1 day, fatigue x 2 days, chills x 1 day, headache x 2 days , swollen lymph nodes started 3 days after vaccine x 1 day, swollen muscle where vaccine administered x 4 days
patient received the first dose of COVID 19 vaccine on 16Dec2020. She got tested positive on 20Dec2020; patient received the first dose of COVID 19 vaccine on 16Dec2020. She got tested positive on 20Dec2020; This is a spontaneous report from a contactable nurse (patient).  A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 16Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of COVID 19 vaccine on 16Dec2020. She got tested positive on 20Dec2020. The patient wanted to know if it's safe for her to get the second dose of covid-19 vaccine scheduled for 07Jan2021. Outcome of the event was unknown.  Information on the Batch/Lot number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with BNT162B2 in this patient might not be completely excluded.
specifically in the stomach area; digestive problems; bacterial infection; verry ill; debilitating symptoms; disability; This is a spontaneous report received from a contactable consumer via Pfizer sponsored program. A 50-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, lot number and expiration date was not reported) via an unspecified route of administration on 28Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Reporter reported behalf of his sister-in-law (patient) who had the first shot of the vaccine on 28JAN2021. The day after she became very ill and at first associated her symptoms with the vaccine. She immediately experienced debilitating symptoms after consulting her doctor, they ruled that out and said that it was a coincidence. She had fatigue and digestive problems from a bacterial infection. Symptoms were that of a bacterial infection, specifically in the stomach area. She received treatment for that and had therapy for a disability. She has yet to receive her 2nd dose. Since she experienced these symptoms, she has been afraid of getting the second dose of the vaccine. Reporter would like to know what to do since she exceeded the recommended three-week window for Pfizer, as well as the six-week window for the CDC. They have consulted with doctors, pharmacist, and was aware of the CDC 42 day window and was asking for what to do with her vaccine. The outcome of the events was unknown.   No further information is expected. Batch/Lot number is not obtained.
Call took two Advil at 1:00 PM. He said that his arm hurt. While driving on the highway to an eye doctors appointment, he complained of dizziness and nausea. Then he slumped against the car door and his eyes rolled back into his head. I had to punch him and scream to get him awake. This happened three times. He said he was sleeping but this was not sleep. Then his teeth began to chatter and he was in a cold sweat.  Maybe the Advil kicked in because he settled down.  After some water in about another 20 minutes, he began to feel better
Sunburn; Condition aggravated//flare in eyes/Sinus/Ears; This spontaneous case was reported by a consumer and describes the occurrence of SUNBURN (Sunburn) and CONDITION AGGRAVATED (Condition aggravated//flare in eyes/Sinus/Ears) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis and Plaque psoriasis.    No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. In February 2022, the patient experienced CONDITION AGGRAVATED (Condition aggravated//flare in eyes/Sinus/Ears). On an unknown date, the patient experienced SUNBURN (Sunburn). At the time of the report, SUNBURN (Sunburn) and CONDITION AGGRAVATED (Condition aggravated//flare in eyes/Sinus/Ears) was resolving.            No Concomitant medications were provided by the reporter. No Treatment medications were provided by the reporter.
Pt received Immunizations on 11/15/10 mom called reported red area where shot given appt 11/17/10 pt has approximately 70cm x 50cm red area (Lt) thigh.
Pt reported dizziness, numbness, anxiety and increased RR Vitals: 12:30 72/36, 45, 23, 96.4F, 100% on RA -- > 12:35 95/52, 107, 20 Pt was given PO fluids and transported to gurney.  Vitals stable. Pt recovered.  Pt stable and released from the vaccination site
This solicited report has been received from a patient's mother, as part of a marketing research program, referring to a young patient (age and gender were unspecified). The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with a dose of GARDASIL (lot #, expiration date, dose and route were not reported). On an unknown date, the patient experienced chronic headaches. The reporter stated that "it is not as safe as other vaccines". The outcome of the chronic headaches was unknown. Additional information is not expected at the reporter did not consent for further follow up.
Received first vaccine shot 9:00 am. Left shoulder. Felt fine all day. Went to bed that evening about 10 pm. Woke up at 11:15 pm with severe shivering, and was extremely cold. My temperature was 98.6. Turned my heat up to 74, added blankets to my bed, could not get warm. Finally had to add a large heat pack to my bed to alleviate shivering. My left shoulder and arm hurt. Abnormally bad sleep. Woke up this morning at 9:30am and am lethargic and very tired. I feel like I was hit by a truck.
This spontaneous report as received from a nurse (medical assistant) via company representative refers to a 30 year old female patient. with Crohn's disease. It was unknown if the patient had any allergies or drug reactions. On 25-JUL-2016, the patient was vaccinated with one unspecified dose of ZOSTAVAX. Concomitant therapies included HUMIRA (also reported as HUMARA), REMICADE and METHOTREXATE. The patient was vaccinated at age of 30 years old. NO treatment was given for adverse event. Lab diagnostic studies were not performed. The patient did not seek medical attention. The patient current status was unknown. Additional information has been requested.
After my Second Shot I felt fine that day but  the next day around 7am in the morning I feel sharp pain in my heart area and dizzy also shortness of breath and can?t get comfortable to sleep without pain since on that side also been experiencing headaches tomorrow will be third day since second dose of Pfizer
syncopal event, patient felt dizzy and was pale, patient was laid back and encouraged to drink water, vital signs stable and resolved by end of 30 minute observation period.
3 days after the shot I was broken out over my entire body from feet to chest, arms as well.
PROQUAD VACCINE IS INTENDED FOR CHILDREN 12 OR UNDER. IT WAS ACCIDENTALLY GIVEN TO AN ADULT
herpes outbreak; This case was reported by a nurse via call center representative and described the occurrence of herpes virus infection in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced herpes virus infection. On an unknown date, the outcome of the herpes virus infection was unknown.   It was unknown if the reporter considered the herpes virus infection to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The patient received 1st dose of Shingrix and experienced herpes outbreak. The healthcare professional would like to receive the Valtrex suppression dose due to herpes outbreak. The patient was due for 2nd dose of Shingrix.
First dose Moderna  Immediately after being vaccinated, while still at vaccine station began to feel nauseated, warm and "a little faint". Was walked over by vaccinator (MD) to a private waiting area to lie down. Was offered water, juice and snacks which he declined. reported tingling of hands bilaterally x 10 min then fully resolved. Vitals: 245: 110/60 and 3 pm 108/54 Pulse 64. Felt fully improved before leaving about 20 minutes later. advised to seek medical care if symptoms return or worsen.